Peabody, MA, United States of America

Kostas Saranteas

USPTO Granted Patents = 13 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 190(Granted Patents)


Location History:

  • Peabody, MA (US) (2003 - 2014)
  • Littleton, MA (US) (2022)

Company Filing History:


Years Active: 2003-2022

Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Kostas Saranteas

Introduction

Kostas Saranteas is a notable inventor based in Peabody, MA (US), recognized for his significant contributions to the field of pharmaceuticals. With a total of 13 patents to his name, Saranteas has made strides in developing novel compounds and methods that address various medical needs.

Latest Patents

Among his latest patents, Saranteas has developed salts, crystal forms, and production methods thereof. This patent includes salts of (S)-(4,5-dihydro-7H-thieno[2,3-c]pyran-7-yl)-N-methylmethanamine and various crystal forms, along with compositions, medicaments, and pharmaceutically acceptable formulations. Additionally, he has introduced methods for treating sleep disorders using eszopiclone maleate, which involves maleate salts of a specific compound that are beneficial for managing sleep-related issues.

Career Highlights

Throughout his career, Kostas Saranteas has worked with prominent companies in the pharmaceutical industry, including Sunovion Pharmaceuticals Inc. and Sepracor, Inc. His work has focused on innovative solutions that enhance the efficacy of treatments in the medical field.

Collaborations

Saranteas has collaborated with esteemed colleagues such as H Scott Wilkinson and Richard Hsia, contributing to the advancement of pharmaceutical research and development.

Conclusion

Kostas Saranteas exemplifies the spirit of innovation in the pharmaceutical industry through his patents and collaborations. His work continues to impact the field positively, addressing critical health challenges with novel solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…